The MidDayBell: How NetraMark’s Explainable AI Could Transform Clinical Trials
George Achilleos, CEO of NetraMark, and Dr. Luca Pani, Chief Innovation & Regulatory Officer, discuss NetraMark’s explainable AI, model-derived subpopulations, a collaboration with NIMH, onboarding with Worldwide Clinical Trials, and an upcoming FDA Critical Path...
AI for Pharma Growth: Quantum Computation In Medicine: The Challenges, What Comes After Large Language Models For Medicine
In this episode, we explore the future of medicine beyond artificial intelligence with Dr. Joseph Geraci — mathematician, medical scientist, and quantum machine learning pioneer. While today’s AI breakthroughs and large language models (LLMs) have transformed...
Driving the Business of Science: AI in Clinical Trials. A Scientist’s Perspective.
AI in Clinical Trials. A Scientist’s Perspective. In this episode of Driving the Business of Science,Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific...